Octopath, a UCL spinout building AI tools for tissue classification, has raised $2.0M in seed funding. Twin Path Ventures and Innovate UK backed the round.
The company grew out of algorithms its founders worked on during their PhDs, and it now builds tools for pathologists - including mitotic figure and margin algorithms - meant to take the repetitive counting and measuring off clinicians' plates.

















